Miaoshou Doctor Completes $73 Million C+ Round at $1 Billion Valuation

03:23 EDT 13 Jul 2019 | ChinaBio Today

Miaoshou Doctor, an online/offline healthcare company headquartered in Beijing, completed a $72.8 million Series C+ financing round, led by Starquest Capital and including Sequoia Capital China along with other investors. Although the round was completed in January, it is now known that the round was priced at a better than $1 billion Unicorn valuation for Miaoshou. The company offers a chain of offline pharmacies, online links between doctors and patients, online healthcare consultation and O2O services. In the previous C round one year ago, Miaoshou raised $79.3 million, led by Tencent. More details....

Share this with colleagues:

Original Article: Miaoshou Doctor Completes $73 Million C+ Round at $1 Billion Valuation


More From BioPortfolio on "Miaoshou Doctor Completes $73 Million C+ Round at $1 Billion Valuation"

Quick Search

Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...